Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Leukemia, Myeloid, Acute 176Leukemia 148Myelodysplastic Syndromes 139Precursor Cell Lymphoblastic Leukemia-Lymphoma 113Lymphoma 80Lymphoma, Non-Hodgkin 73Leukemia, Lymphocytic, Chronic, B-Cell 70Hodgkin Disease 64Congenital Abnormalities 63Leukemia, Myeloid, Chronic-Phase 60Multiple Myeloma 58Myeloproliferative Disorders 54Leukemia, Myelomonocytic, Chronic 53Leukemia, Myeloid, Accelerated Phase 53Lymphoma, Large B-Cell, Diffuse 50Lymphoma, Follicular 50Lymphoma, Mantle-Cell 47Burkitt Lymphoma 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Blast Crisis 44Lymphoma, Large-Cell, Immunoblastic 43Anemia, Refractory, with Excess of Blasts 43Neoplasms, Plasma Cell 41Hematologic Neoplasms 35Graft vs Host Disease 35Primary Myelofibrosis 33Myelodysplastic-Myeloproliferative Diseases 33Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 32Dendritic Cell Sarcoma, Interdigitating 32

Interventions

fludarabine 4fludarabine phosphate 3Thiotepa 2Melphalan 2Clofarabine 2Busulfan 2AP 1903 reagent 2Tacrolimus 1Photopheresis 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Glucose Tolerance Test 1Cyclosporins 1Cyclophosphamide 1Continuous Glucose Monitoring 1Clinical Trials, Phase I as Topic 1Bone Marrow Transplantation 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hemoglobinopathies × Busulfan × Other hematologic neoplasm × Clear all
NCT04644016 2026-03-13

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
31 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡